I have been doing some research on upcoming conference program (it's huge) and Aztrazenica's most likely' these are the drug combination that AZ may have used the Dendrimer as a scaffold to improve application and efficacy so let us see if I am right or wrong? ( this is where we miss Biotechanalyst hope he is happy with SPL's progress this week)
- Forums
- ASX - By Stock
- SPL
- Pembrolizumab/DuralumabDEP
Pembrolizumab/DuralumabDEP
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SPL (ASX) to my watchlist
|
|||||
Last
9.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $40.48M |
Open | High | Low | Value | Volume |
9.8¢ | 9.8¢ | 9.7¢ | $28.43K | 290.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 28889 | 9.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.8¢ | 181077 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 28889 | 0.097 |
2 | 155000 | 0.096 |
4 | 126904 | 0.095 |
1 | 100000 | 0.093 |
1 | 50000 | 0.092 |
Price($) | Vol. | No. |
---|---|---|
0.098 | 181077 | 1 |
0.100 | 101200 | 2 |
0.105 | 144450 | 5 |
0.110 | 233058 | 6 |
0.115 | 109827 | 3 |
Last trade - 10.42am 04/09/2024 (20 minute delay) ? |
Featured News
SPL (ASX) Chart |